Composite medicine for treating toothache quickly and effectively

A technology for medicine and toothache, which is applied in the field of compound medicine for quick-acting treatment of toothache, can solve the problems of not being able to relieve the pain of the patient quickly, easy to relapse, short maintenance time, etc., and achieve safe and reliable medicine, simple production, and convenient administration Effect

Inactive Publication Date: 2008-05-28
严晓丽
View PDF0 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The etiology of toothache is diverse, such as wind-fired teeth caused by wind and cold, tooth decay caused by children eating too much sugar, periodontitis, gingivitis, and other allergic and nervous toothaches. The treatm

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0011] Embodiment one: get antibacterial and anti-inflammatory drug cephalexin (or cephradine, or amoxicillin, or levofloxacin, or ofloxacin, or ciprofloxacin), tiapride hydrochloride, metronidazole (or tinidazole, or ciprofloxacin) respectively or ornidazole), indomethacin enteric-coated tablets, prednisone hydrochloride, phenylbutazone powder medicines by weight 5: 4: 8: 1: 0.2: 4 proportioning, the powder is fully mixed, and packed into capsules The weight of medicine loaded in each capsule is 0.55-0.56g. Patients with toothache should take one capsule at a time, and then another capsule at intervals of 5 hours, about two times to consolidate the course of treatment. In this embodiment, the compound medicine is compounded according to the ratio of 5:4:8:1:4:0.2 in weight parts of each combined medicine, fully mixed in powder form, and packed into capsules as a finished medicine.

Embodiment 2

[0012] Embodiment two: get antibacterial and anti-inflammatory drug 0.125g cephalexin (or 0.25g cephradine, or 0.25g amoxicillin, or 0.1g levofloxacin, or 0.1g ofloxacin, or 0.25g ciprofloxacin) one piece, antibacterial and anti-inflammatory drug respectively Mental sensitive drugs 100mg tiapride hydrochloride one tablet, anti-anaerobic infection drugs 0.2g metronidazole (or 0.5g tinidazole, or 0.5g ornidazole) one tablet, anti-inflammatory and analgesic drugs 25mg indomethacin enteric-coated tablets, 0.1 One tablet of phenylbutazone and one tablet of prednisone hydrochloride 5mg to increase the curative effect, a total of six tablets are given to patients with toothache once. According to the statistics, generally taking half an hour at a time can relieve pain, and then take the second and third times every 5 hours to consolidate the curative effect, that is to say, cure. Of course, if it is a fundamental tooth lesion, you should go to the stomatology department for consultat...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention particularly relates to a drug for rapid-acting treatment of toothache. The drug integrates various causes of toothache disease and carries out the compounding of antibiotic anti-inflammatory drug, anti-spirit sensitivity drug, anti-anaerobic infection drug, anti-inflammatory analgesic drug and other various western patent drugs, and the compound drug mainly consists of drug cefalexin or other antibiotic anti-inflammatory drug, tiapride hydrochloride, metronidazole or other anti-anaerobic infection drug, indometacin enteric-coated tablet, phenylbutazone and prednisone hydrochloride sequentially according to the mixing ratio by weight parts. The drug of the invention is rapid in acting for the toothache disease which is formed by various causes, and generally the drug can act in 1 to 1.5 hours after the drug administration, the pain can be stopped after one week of the drug administration, and the effect is significant; the effective rate of the rapid pain stopping is 98 percent and the cure rate is 96.5 percent according to the statistics; the used drugs of the invention are the patent drugs which are proved by the state and the efficacies of the drugs are safe and reliable; the administration is convenient, which is easy to be accepted by patients.

Description

technical field [0001] The invention relates to a medicine for treating toothache, in particular to a compound medicine for quickly treating toothache. Background technique [0002] "Toothache" is a common multiple oral disease. Once people have "toothache", they will suffer unbearably and have trouble sleeping and eating, which will seriously affect the patient's work, study and life. Moreover, the "toothache" disease will recur, and he (she) needs to endure the torment of the disease. At present, doctors mainly rely on oral medicine, water hanging or acupuncture at the pain point, and external application of ointment to treat toothache. The etiology of toothache is diverse, such as wind-fired teeth caused by wind and cold, tooth decay caused by children eating too much sugar, periodontitis, gingivitis, and other allergic and nervous toothaches. Therapeutic method can only reach certain analgesic effect to because of some kind of toothache disease, but usually slow onset,...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K45/06A61K31/573A61K31/496A61K31/5383A61P1/02A61P31/02A61K31/166A61K31/405A61K31/4152A61K31/4164A61K31/43A61K31/545
Inventor 严晓丽
Owner 严晓丽
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap